256 related articles for article (PubMed ID: 36683710)
1. Endoscopic ultrasound guided radiofrequency ablation for pancreatic tumors: A critical review focusing on safety, efficacy and controversies.
Khoury T; Sbeit W; Napoléon B
World J Gastroenterol; 2023 Jan; 29(1):157-170. PubMed ID: 36683710
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumors and pancreatic cystic neoplasms: a prospective multicenter study.
Barthet M; Giovannini M; Lesavre N; Boustiere C; Napoleon B; Koch S; Gasmi M; Vanbiervliet G; Gonzalez JM
Endoscopy; 2019 Sep; 51(9):836-842. PubMed ID: 30669161
[TBL] [Abstract][Full Text] [Related]
3. Endoscopic ultrasound-guided radiofrequency ablation of premalignant pancreatic-cystic neoplasms and neuroendocrine tumors: prospective study.
Younis F; Ben-Ami Shor D; Lubezky N; Geva R; Osher E; Shibolet O; Phillips A; Scapa E
Eur J Gastroenterol Hepatol; 2022 Nov; 34(11):1111-1115. PubMed ID: 36170679
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic ultrasound-guided ethanol ablation therapy for tumors.
Zhang WY; Li ZS; Jin ZD
World J Gastroenterol; 2013 Jun; 19(22):3397-403. PubMed ID: 23801831
[TBL] [Abstract][Full Text] [Related]
5. Management of non-functional pancreatic neuroendocrine tumors by endoscopic ultrasound-guided radiofrequency ablation: Retrospective study in two tertiary centers.
Marx M; Godat S; Caillol F; Poizat F; Ratone JP; Pesenti C; Schoepfer A; Hoibian S; Dahel Y; Giovannini M
Dig Endosc; 2022 Sep; 34(6):1207-1213. PubMed ID: 34963025
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic ultrasound-guided radiofrequency ablation for management of benign solid pancreatic tumors.
Choi JH; Seo DW; Song TJ; Park DH; Lee SS; Lee SK; Kim MH
Endoscopy; 2018 Nov; 50(11):1099-1104. PubMed ID: 29727904
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic ablation therapy for the pancreatic neoplasms.
Matsumoto K; Kato H
Dig Endosc; 2023 May; 35(4):430-442. PubMed ID: 36366955
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Neuroendocrine Tumors: A Systematic Review and Metanalysis.
Armellini E; Facciorusso A; Crinò SF
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837560
[No Abstract] [Full Text] [Related]
9. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic microcystic serous cystic neoplasms: a retrospective study.
Oh D; Ko SW; Seo DW; Hong SM; Kim JH; Song TJ; Park DH; Lee SK; Kim MH
Endoscopy; 2021 Jul; 53(7):739-743. PubMed ID: 33063298
[TBL] [Abstract][Full Text] [Related]
10. Technique, safety, and feasibility of EUS-guided radiofrequency ablation in unresectable pancreatic cancer.
Scopelliti F; Pea A; Conigliaro R; Butturini G; Frigerio I; Regi P; Giardino A; Bertani H; Paini M; Pederzoli P; Girelli R
Surg Endosc; 2018 Sep; 32(9):4022-4028. PubMed ID: 29766302
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience.
Borrelli de Andreis F; Boškoski I; Mascagni P; Schepis T; Bianchi A; Schinzari G; Annicchiarico BE; Quero G; Tortora G; Alfieri S; Gasbarrini A; Costamagna G; Spada C; Attili F
Pancreatology; 2023 Aug; 23(5):543-549. PubMed ID: 37236853
[TBL] [Abstract][Full Text] [Related]
12. EUS-guided Radiofrequency Ablation (EUS-RFA) of Solid Pancreatic Neoplasm Using an 18-gauge Needle Electrode: Feasibility, Safety, and Technical Success.
Crinò SF; D'Onofrio M; Bernardoni L; Frulloni L; Iannelli M; Malleo G; Paiella S; Larghi A; Gabbrielli A
J Gastrointestin Liver Dis; 2018 Mar; 27(1):67-72. PubMed ID: 29557417
[TBL] [Abstract][Full Text] [Related]
13. EUS-guided ablation of pancreatic neoplasms.
Rimbaș M; Rizzatti G; Larghi A
Minerva Gastroenterol (Torino); 2022 Jun; 68(2):186-201. PubMed ID: 33871223
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for advanced pancreatic and periampullary adenocarcinoma.
Thosani N; Cen P; Rowe J; Guha S; Bailey-Lundberg JM; Bhakta D; Patil P; Wray CJ
Sci Rep; 2022 Oct; 12(1):16516. PubMed ID: 36192558
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic Ultrasound-Guided Radiofrequency Ablation: A New Therapeutic Approach for Pancreatic Neuroendocrine Tumors.
Oleinikov K; Dancour A; Epshtein J; Benson A; Mazeh H; Tal I; Matalon S; Benbassat CA; Livovsky DM; Goldin E; Gross DJ; Jacob H; Grozinsky-Glasberg S
J Clin Endocrinol Metab; 2019 Jul; 104(7):2637-2647. PubMed ID: 31102458
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for Treatment of Pancreatic Insulinoma.
Crinò SF; Napoleon B; Facciorusso A; Lakhtakia S; Borbath I; Caillol F; Do-Cong Pham K; Rizzatti G; Forti E; Palazzo L; Belle A; Vilmann P; van Laethem JL; Mohamadnejad M; Godat S; Hindryckx P; Benson A; Tacelli M; De Nucci G; Binda C; Kovacevic B; Jacob H; Partelli S; Falconi M; Salvia R; Landoni L; ; Larghi A
Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2834-2843.e2. PubMed ID: 36871765
[TBL] [Abstract][Full Text] [Related]
17. The Safety and Efficacy of an Alcohol-Free Pancreatic Cyst Ablation Protocol.
Moyer MT; Sharzehi S; Mathew A; Levenick JM; Headlee BD; Blandford JT; Heisey HD; Birkholz JH; Ancrile BB; Maranki JL; Gusani NJ; McGarrity TJ; Dye CE
Gastroenterology; 2017 Nov; 153(5):1295-1303. PubMed ID: 28802565
[TBL] [Abstract][Full Text] [Related]
18. EUS-guided radiofrequency ablation for pancreatic insulinoma: experience in 2 tertiary centers.
Marx M; Trosic-Ivanisevic T; Caillol F; Demartines N; Schoepfer A; Pesenti C; Ratone JP; Robert M; Giovannini M; Godat S
Gastrointest Endosc; 2022 Jun; 95(6):1256-1263. PubMed ID: 34902374
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis.
Khoury T; Sbeit W; Fusaroli P; Campana D; Brighi N; Napoleon B; Lisotti A
Dig Endosc; 2024 Apr; 36(4):395-405. PubMed ID: 37702096
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for EUS-guided radiofrequency ablation adverse events in patients with pancreatic neoplasms: a large national French study (RAFPAN study).
Napoléon B; Lisotti A; Caillol F; Gasmi M; Ah-Soune P; Belle A; Charachon A; Cholet F; Eyraud PY; Grandval P; Gonzalez JM; Habersetzer F; Koch S; Le Rhun M; Mangialavori L; Musquer N; Palazzo M; Poincloux L; Privat J; Sportes A; Stouvenot M; Subtil C; Thomassin L; Vanbiervliet G; Vidal G; Vuitton L; Giovannini M; Barthet M
Gastrointest Endosc; 2023 Sep; 98(3):392-399.e1. PubMed ID: 37059368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
